Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 858 entries
Sorted by: Best Match Show Resources per page
Editorial.

International journal of psychiatry in clinical practice

Kasper S, Baldwin D.
PMID: 24930786
Int J Psychiatry Clin Pract. 2005;9(2):77-8. doi: 10.1080/13651500510029156.

No abstract available.

Cite
Kasper S, Baldwin D. Editorial. Int J Psychiatry Clin Pract. 2005;9(2):77-8doi: 10.1080/13651500510029156.
Kasper, S., & Baldwin, D. (2005). Editorial. International journal of psychiatry in clinical practice, 9(2), 77-8. https://doi.org/10.1080/13651500510029156
Kasper, Siegfried, and Baldwin, David. "Editorial." International journal of psychiatry in clinical practice vol. 9,2 (2005): 77-8. doi: https://doi.org/10.1080/13651500510029156
Kasper S, Baldwin D. Editorial. Int J Psychiatry Clin Pract. 2005;9(2):77-8. doi: 10.1080/13651500510029156. PMID: 24930786.
Copy Download .nbib Format: NLM
Correlates of subjective well-being in schizophrenic patients treated with atypical antipsychotics.

International journal of psychiatry in clinical practice

Schimmelmann BG, Moritz S, Karow A, Schafer I, Bussopulos A, Golks D, Krausz M, Naber D, Lambert M.
PMID: 24930789
Int J Psychiatry Clin Pract. 2005;9(2):94-8. doi: 10.1080/13651500510018266.

Objective A growing body of research indicates that a low subjective well-being (SW) may be predictive of non-adherence and less favourable outcome. This study examined baseline variables and variables in the course of treatment hypothesised to be associated with...

Cite
Schimmelmann BG, Moritz S, Karow A, et al. Correlates of subjective well-being in schizophrenic patients treated with atypical antipsychotics. Int J Psychiatry Clin Pract. 2005;9(2):94-8doi: 10.1080/13651500510018266.
Schimmelmann, B. G., Moritz, S., Karow, A., Schafer, I., Bussopulos, A., Golks, D., Krausz, M., Naber, D., & Lambert, M. (2005). Correlates of subjective well-being in schizophrenic patients treated with atypical antipsychotics. International journal of psychiatry in clinical practice, 9(2), 94-8. https://doi.org/10.1080/13651500510018266
Schimmelmann, B G, et al. "Correlates of subjective well-being in schizophrenic patients treated with atypical antipsychotics." International journal of psychiatry in clinical practice vol. 9,2 (2005): 94-8. doi: https://doi.org/10.1080/13651500510018266
Schimmelmann BG, Moritz S, Karow A, Schafer I, Bussopulos A, Golks D, Krausz M, Naber D, Lambert M. Correlates of subjective well-being in schizophrenic patients treated with atypical antipsychotics. Int J Psychiatry Clin Pract. 2005;9(2):94-8. doi: 10.1080/13651500510018266. PMID: 24930789.
Copy Download .nbib Format: NLM
A prescription survey of antipsychotic use in England and Wales following the introduction of NICE guidance.

International journal of psychiatry in clinical practice

MacE S, Taylor D.
PMID: 24930794
Int J Psychiatry Clin Pract. 2005;9(2):124-9. doi: 10.1080/13651500510028995.

Objective : In the United Kingdom (UK) the National Institute for Clinical Excellence (NICE) has recommended the use of atypical antipsychotics for the treatment of schizophrenia. As part of its guidance it discourages the concurrent use of typical and...

Cite
MacE S, Taylor D. A prescription survey of antipsychotic use in England and Wales following the introduction of NICE guidance. Int J Psychiatry Clin Pract. 2005;9(2):124-9doi: 10.1080/13651500510028995.
MacE, S., & Taylor, D. (2005). A prescription survey of antipsychotic use in England and Wales following the introduction of NICE guidance. International journal of psychiatry in clinical practice, 9(2), 124-9. https://doi.org/10.1080/13651500510028995
MacE, Shubhra, and Taylor, David. "A prescription survey of antipsychotic use in England and Wales following the introduction of NICE guidance." International journal of psychiatry in clinical practice vol. 9,2 (2005): 124-9. doi: https://doi.org/10.1080/13651500510028995
MacE S, Taylor D. A prescription survey of antipsychotic use in England and Wales following the introduction of NICE guidance. Int J Psychiatry Clin Pract. 2005;9(2):124-9. doi: 10.1080/13651500510028995. PMID: 24930794.
Copy Download .nbib Format: NLM
Belgian consensus on metabolic problems associated with atypical antipsychotics.

International journal of psychiatry in clinical practice

De Nayer A, De Hert M, Scheen A, Van Gaal L, Peuskens J, On Behalf Of The Consensus Group, De Nayer A, De Hert M, Scheen A, Van Gaal L, Peuskens J, On Behalf Of The Consensus Group.
PMID: 24930795
Int J Psychiatry Clin Pract. 2005;9(2):130-7. doi: 10.1080/13651500510018310.

A workshop was convened by a panel of psychiatrists, diabetologists and pharmacists from major Belgian hospitals to review the latest information relating to the risks with second-generation antipsychotics (SGA) for the development of metabolic disorders, especially impaired glucose tolerance,...

Cite
De Nayer A, De Hert M, Scheen A, et al. Belgian consensus on metabolic problems associated with atypical antipsychotics. Int J Psychiatry Clin Pract. 2005;9(2):130-7doi: 10.1080/13651500510018310.
De Nayer, A., De Hert, M., Scheen, A., Van Gaal, L., Peuskens, J., On Behalf Of The Consensus Group, De Nayer, A., De Hert, M., Scheen, A., Van Gaal, L., Peuskens, J., & On Behalf Of The Consensus Group. (2005). Belgian consensus on metabolic problems associated with atypical antipsychotics. International journal of psychiatry in clinical practice, 9(2), 130-7. https://doi.org/10.1080/13651500510018310
De Nayer, A, et al. "Belgian consensus on metabolic problems associated with atypical antipsychotics." International journal of psychiatry in clinical practice vol. 9,2 (2005): 130-7. doi: https://doi.org/10.1080/13651500510018310
De Nayer A, De Hert M, Scheen A, Van Gaal L, Peuskens J, On Behalf Of The Consensus Group, De Nayer A, De Hert M, Scheen A, Van Gaal L, Peuskens J, On Behalf Of The Consensus Group. Belgian consensus on metabolic problems associated with atypical antipsychotics. Int J Psychiatry Clin Pract. 2005;9(2):130-7. doi: 10.1080/13651500510018310. PMID: 24930795.
Copy Download .nbib Format: NLM
Acute psychological stress-induced water intoxication.

International journal of psychiatry in clinical practice

Mukherjee S, Antonarakis ES, Asaduzzaman S, Peters JR.
PMID: 24930797
Int J Psychiatry Clin Pract. 2005;9(2):142-4. doi: 10.1080/13651500510028986.

Excessive water drinking is a recognised feature of schizophrenia. We present here a case of excessive water drinking precipitated by acute psychological stress. A 52-year-old woman, with no previous mental health problems, was found in a state of altered...

Cite
Mukherjee S, Antonarakis ES, Asaduzzaman S, et al. Acute psychological stress-induced water intoxication. Int J Psychiatry Clin Pract. 2005;9(2):142-4doi: 10.1080/13651500510028986.
Mukherjee, S., Antonarakis, E. S., Asaduzzaman, S., & Peters, J. R. (2005). Acute psychological stress-induced water intoxication. International journal of psychiatry in clinical practice, 9(2), 142-4. https://doi.org/10.1080/13651500510028986
Mukherjee, Sagarika, et al. "Acute psychological stress-induced water intoxication." International journal of psychiatry in clinical practice vol. 9,2 (2005): 142-4. doi: https://doi.org/10.1080/13651500510028986
Mukherjee S, Antonarakis ES, Asaduzzaman S, Peters JR. Acute psychological stress-induced water intoxication. Int J Psychiatry Clin Pract. 2005;9(2):142-4. doi: 10.1080/13651500510028986. PMID: 24930797.
Copy Download .nbib Format: NLM
Erratum.

International journal of psychiatry in clinical practice

[No authors listed]
PMID: 28353354
Int J Psychiatry Clin Pract. 2017 Jun;21(2):161. doi: 10.1080/13651501.2017.1308115. Epub 2017 Mar 29.

No abstract available.

Cite
Erratum. Int J Psychiatry Clin Pract. 2017;21(2):161doi: 10.1080/13651501.2017.1308115.
(2017). Erratum. International journal of psychiatry in clinical practice, 21(2), 161. https://doi.org/10.1080/13651501.2017.1308115
"Erratum." International journal of psychiatry in clinical practice vol. 21,2 (2017): 161. doi: https://doi.org/10.1080/13651501.2017.1308115
Erratum. Int J Psychiatry Clin Pract. 2017 Jun;21(2):161. doi: 10.1080/13651501.2017.1308115. Epub 2017 Mar 29. PMID: 28353354.
Copy Download .nbib Format: NLM
Olanzapine in subjects with a first-episode psychosis non-responsive, intolerant or non-compliant to a first-line trial of risperidone.

International journal of psychiatry in clinical practice

Lambert M, Conus P, Naber D, Mcgorry PD, Schimmelmann BG.
PMID: 24930921
Int J Psychiatry Clin Pract. 2005;9(4):244-50. doi: 10.1080/13651500500328418.

Objective. Investigation of the efficacy and tolerability of olanzapine (OLZ) as second-line treatment in subjects with a first-episode psychosis (FEP) who had been non-responsive, intolerant or non-compliant to Risperidone (RIS). Methods. The Early Psychosis Prevention and Intervention Centre in...

Cite
Lambert M, Conus P, Naber D, et al. Olanzapine in subjects with a first-episode psychosis non-responsive, intolerant or non-compliant to a first-line trial of risperidone. Int J Psychiatry Clin Pract. 2005;9(4):244-50doi: 10.1080/13651500500328418.
Lambert, M., Conus, P., Naber, D., Mcgorry, P. D., & Schimmelmann, B. G. (2005). Olanzapine in subjects with a first-episode psychosis non-responsive, intolerant or non-compliant to a first-line trial of risperidone. International journal of psychiatry in clinical practice, 9(4), 244-50. https://doi.org/10.1080/13651500500328418
Lambert, Martin, et al. "Olanzapine in subjects with a first-episode psychosis non-responsive, intolerant or non-compliant to a first-line trial of risperidone." International journal of psychiatry in clinical practice vol. 9,4 (2005): 244-50. doi: https://doi.org/10.1080/13651500500328418
Lambert M, Conus P, Naber D, Mcgorry PD, Schimmelmann BG. Olanzapine in subjects with a first-episode psychosis non-responsive, intolerant or non-compliant to a first-line trial of risperidone. Int J Psychiatry Clin Pract. 2005;9(4):244-50. doi: 10.1080/13651500500328418. PMID: 24930921.
Copy Download .nbib Format: NLM
Editorial.

International journal of psychiatry in clinical practice

Baldwin D, Kasper S.
PMID: 24931653
Int J Psychiatry Clin Pract. 2008;12(3):163-4. doi: 10.1080/13651500802256838.

No abstract available.

Cite
Baldwin D, Kasper S. Editorial. Int J Psychiatry Clin Pract. 2008;12(3):163-4doi: 10.1080/13651500802256838.
Baldwin, D., & Kasper, S. (2008). Editorial. International journal of psychiatry in clinical practice, 12(3), 163-4. https://doi.org/10.1080/13651500802256838
Baldwin, David, and Kasper, Siegfried. "Editorial." International journal of psychiatry in clinical practice vol. 12,3 (2008): 163-4. doi: https://doi.org/10.1080/13651500802256838
Baldwin D, Kasper S. Editorial. Int J Psychiatry Clin Pract. 2008;12(3):163-4. doi: 10.1080/13651500802256838. PMID: 24931653.
Copy Download .nbib Format: NLM
Olanzapine in the treatment of depression with psychotic features: A prospective open-label study.

International journal of psychiatry in clinical practice

Adli M, Wiethoff K, Baethge C, Pfennig A, Stamm T, Bauer M.
PMID: 24931659
Int J Psychiatry Clin Pract. 2008;12(3):202-9. doi: 10.1080/13651500801911144.

Objective. Depression with psychotic features is a severe subtype of major depression associated with the presence of delusions, hallucinations and specific neurobiological features. Despite clinical consensus and guideline recommendations, data comparing the efficacy of combining antipsychotics with antidepressants compared...

Cite
Adli M, Wiethoff K, Baethge C, et al. Olanzapine in the treatment of depression with psychotic features: A prospective open-label study. Int J Psychiatry Clin Pract. 2008;12(3):202-9doi: 10.1080/13651500801911144.
Adli, M., Wiethoff, K., Baethge, C., Pfennig, A., Stamm, T., & Bauer, M. (2008). Olanzapine in the treatment of depression with psychotic features: A prospective open-label study. International journal of psychiatry in clinical practice, 12(3), 202-9. https://doi.org/10.1080/13651500801911144
Adli, Mazda, et al. "Olanzapine in the treatment of depression with psychotic features: A prospective open-label study." International journal of psychiatry in clinical practice vol. 12,3 (2008): 202-9. doi: https://doi.org/10.1080/13651500801911144
Adli M, Wiethoff K, Baethge C, Pfennig A, Stamm T, Bauer M. Olanzapine in the treatment of depression with psychotic features: A prospective open-label study. Int J Psychiatry Clin Pract. 2008;12(3):202-9. doi: 10.1080/13651500801911144. PMID: 24931659.
Copy Download .nbib Format: NLM
Effectiveness of a structured diet program in antipsychotic-induced weight gain in patients with schizophrenia.

International journal of psychiatry in clinical practice

Direk N, Ucok A.
PMID: 24931664
Int J Psychiatry Clin Pract. 2008;12(3):238-40. doi: 10.1080/13651500701574554.

Objective.The aim of this study was to evaluate the effectiveness of a structured diet program in weight loss in patients with schizophrenia. Methods. A total of 38 outpatients diagnosed with schizophrenia according to DSM-IV and who had complaints of...

Cite
Direk N, Ucok A. Effectiveness of a structured diet program in antipsychotic-induced weight gain in patients with schizophrenia. Int J Psychiatry Clin Pract. 2008;12(3):238-40doi: 10.1080/13651500701574554.
Direk, N., & Ucok, A. (2008). Effectiveness of a structured diet program in antipsychotic-induced weight gain in patients with schizophrenia. International journal of psychiatry in clinical practice, 12(3), 238-40. https://doi.org/10.1080/13651500701574554
Direk, Nese, and Ucok, Alp. "Effectiveness of a structured diet program in antipsychotic-induced weight gain in patients with schizophrenia." International journal of psychiatry in clinical practice vol. 12,3 (2008): 238-40. doi: https://doi.org/10.1080/13651500701574554
Direk N, Ucok A. Effectiveness of a structured diet program in antipsychotic-induced weight gain in patients with schizophrenia. Int J Psychiatry Clin Pract. 2008;12(3):238-40. doi: 10.1080/13651500701574554. PMID: 24931664.
Copy Download .nbib Format: NLM
Paroxetine versus amitriptyline in patients with recurrent major depression: A double-blind trial.

International journal of psychiatry in clinical practice

Sacchetti E, Cassano GB, Penati G, Pavan L, Nardini M, Casacchia M, Pancheri P, Muscettola G, Faravelli C, Aguglia E, Nivoli G, Ravizza L, Castrogiovanni P.
PMID: 24931886
Int J Psychiatry Clin Pract. 2002;6(1):23-9. doi: 10.1080/136515002753489380.

INTRODUCTION: Long-term exposure to antidepressants is required to prevent relapses and recurrences in patients with recurrent major depression. Furthermore, a good pharmacological compliance is the key to successful long-term treatment. Since the early phases of a treatment influence long-term...

Cite
Sacchetti E, Cassano GB, Penati G, et al. Paroxetine versus amitriptyline in patients with recurrent major depression: A double-blind trial. Int J Psychiatry Clin Pract. 2002;6(1):23-9doi: 10.1080/136515002753489380.
Sacchetti, E., Cassano, G. B., Penati, G., Pavan, L., Nardini, M., Casacchia, M., Pancheri, P., Muscettola, G., Faravelli, C., Aguglia, E., Nivoli, G., Ravizza, L., & Castrogiovanni, P. (2002). Paroxetine versus amitriptyline in patients with recurrent major depression: A double-blind trial. International journal of psychiatry in clinical practice, 6(1), 23-9. https://doi.org/10.1080/136515002753489380
Sacchetti, Emilio, et al. "Paroxetine versus amitriptyline in patients with recurrent major depression: A double-blind trial." International journal of psychiatry in clinical practice vol. 6,1 (2002): 23-9. doi: https://doi.org/10.1080/136515002753489380
Sacchetti E, Cassano GB, Penati G, Pavan L, Nardini M, Casacchia M, Pancheri P, Muscettola G, Faravelli C, Aguglia E, Nivoli G, Ravizza L, Castrogiovanni P. Paroxetine versus amitriptyline in patients with recurrent major depression: A double-blind trial. Int J Psychiatry Clin Pract. 2002;6(1):23-9. doi: 10.1080/136515002753489380. PMID: 24931886.
Copy Download .nbib Format: NLM
Month of birth and suicide: An exploratory study.

International journal of psychiatry in clinical practice

Salib E.
PMID: 24931890
Int J Psychiatry Clin Pract. 2002;6(1):39-44. doi: 10.1080/136515002753489407.

OBJECTIVE: To explore the association between suicide and month of birth.METHOD: Data were extracted from records of the Public Health Department in North Cheshire between 1989 and 2000. ¤ Suicide' refers to all deceased who were the subjects of...

Cite
Salib E. Month of birth and suicide: An exploratory study. Int J Psychiatry Clin Pract. 2002;6(1):39-44doi: 10.1080/136515002753489407.
Salib, E. (2002). Month of birth and suicide: An exploratory study. International journal of psychiatry in clinical practice, 6(1), 39-44. https://doi.org/10.1080/136515002753489407
Salib, Emad. "Month of birth and suicide: An exploratory study." International journal of psychiatry in clinical practice vol. 6,1 (2002): 39-44. doi: https://doi.org/10.1080/136515002753489407
Salib E. Month of birth and suicide: An exploratory study. Int J Psychiatry Clin Pract. 2002;6(1):39-44. doi: 10.1080/136515002753489407. PMID: 24931890.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 858 entries